Chicago Atlantic BDC Inc

Chicago Atlantic BDC Inc (LIEN) Stock Analysis

$9.200

+0.101 (+1.10%)At close

Loading chart…
High
9.250
Open
9.110
VWAP
9.19
Volume
17.50K
Mkt Cap
—
Low
9.110
Amount
160.80K
EV/EBITDA, TTM
-0.23

Chicago Atlantic BDC, Inc. is a specialty finance company. The Company’s investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies in the health and wellness sector. It has typically invested in and expects to continue to invest in loans made primarily to private leveraged lower middle-market and middle-market companies. Its business model is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. The Company may also invest in growth and technology companies, esoteric and asset-based lending opportunities, and liquidity solutions opportunities. The Company is managed by Chicago Atlantic BDC Advisers, LLC, an investment manager focused on the cannabis and other niche or underfollowed sectors.

AI analysis of Chicago Atlantic BDC Inc (LIEN)

Hold

While LIEN has a strong dividend yield of 13.19% and a forward P/E ratio of 5.58, indicating potential value, the stock has underperformed with a year-to-date change of -11.98% and a recent RSI of 42.22, suggesting it is nearing oversold territory but not yet a strong buy signal. The main risk is the recent decline in net income to common shareholders, which dropped to $6,064,079 in Q2 2026 from $8,534,388 in Q1 2026, indicating potential profitability concerns.

Valuation Metrics

The current forward P/E ratio for Chicago Atlantic BDC Inc (LIEN) is 5.61, compared to its 5-year average forward P/E of 6.58.

Forward P/E

Undervalued
5Y Average P/E
6.58
Current P/E
5.61
Overvalued
7.18
Undervalued
5.98

Forward EV/EBITDA

Fair
5Y Average EV/EBITDA
84.70
Current EV/EBITDA
-0.23
Overvalued
282.91
Undervalued
-113.51

Forward P/S

Undervalued
5Y Average P/S
3.32
Current P/S
3.07
Overvalued
3.53
Undervalued
3.12

Alphio AI Price Scenarios for LIEN

Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.

B

Bull

Bull · 25%LIEN

$10.25

Scenario price

B

Base

Base · 50%LIEN

$9.62

Scenario price

B

Bear

Bear · 25%LIEN

$7.94

Scenario price

Events Timeline

2026-05-11 (ET)

16:20:00

Chicago Atlantic BDC Files for $500M Securities Registration

2026-03-19 (ET)

07:10:00

Chicago Atlantic BDC Reports $14.2M Investment Income

2025-11-13 (ET)

07:15:20

Chicago Atlantic BDC Announces Q3 NII per Share of 42 Cents, Up from 34 Cents Last Quarter

2025-08-14 (ET)

07:07:36

Chicago Atlantic BDC reports Q2 NII 34c vs. 38c last year

2025-05-14 (ET)

07:14:32

Chicago Atlantic BDC reports Q1 EPS 33c vs 35c last year

News

LIEN FAQ — answered by Alphio AI

Chicago Atlantic BDC, Inc. is a specialty finance company. The Company’s investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a focus on cannabis companies in the health and wellness sector. It has typically invested in and expects to continue to invest in loans made primarily to private leveraged lower middle-market and middle-market companies. Its business model is focused primarily on the direct origination of investments through portfolio companies or their financial sponsors. The Company may also invest in growth and technology companies, esoteric and asset-based lending opportunities, and liquidity solutions opportunities. The Company is managed by Chicago Atlantic BDC Advisers, LLC, an investment manager focused on the cannabis and other niche or underfollowed sectors. It operates in the Financials sector.

While LIEN has a strong dividend yield of 13.19% and a forward P/E ratio of 5.58, indicating potential value, the stock has underperformed with a year-to-date change of -11.98% and a recent RSI of 42.22, suggesting it is nearing oversold territory but not yet a strong buy signal. The main risk is the recent decline in net income to common shareholders, which dropped to $6,064,079 in Q2 2026 from $8,534,388 in Q1 2026, indicating potential profitability concerns.

Community

More ↗

No posts yet

Sign up or log in to join the discussion

Related articles

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.

Start trading